The network leads clinical trials that address antibacterial resistance threats

Friday, December 13, 2019 NIH Renews Funding for the Antibacterial Resistance Leadership Group As antibiotic-resistant bacteria become more urgent threats worldwide, NIAID is pleased to announce its ongoing support for the Antibacterial Resistance Leadership Group (ARLG), a global consortium of scientific experts who oversee important clinical research on antibacterial resistance. This renewed funding will allow the ARLG to conduct and support critical research for an additional seven years. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107